Travoprost, a prostaglandin F2α analogue, is a full agonist which is highly selective and has a high affinity for the prostaglandin FP receptor, and reduces the intraocular pressure by increasing the outflow of aqueous humour via trabecular meshwork and uveoscleral pathways.
Nedsætter det intraokulære tryk ved at øge outflowet af kammervæske via trabekelværket og de uveosklerale veje.